As lockdowns ease, Olivier Pourret hopes that academia will take on board lessons about how to redefine career success.
A fresh take on scientific workforce diversity approaching it as a scientific opportunity rather than as an intractable problem.
Analyzing Open Access levels across all countries and fields of research with Google Scholar data.
The case of Switzerland is a clear example of how a "no" vote could damage UK science.
Scientists and the design of experiments under scrutiny after a major project fails to reproduce results of high profile studies.
More than 90 countries are using Covid shots from China. Experts say recent infections in those places should serve as a cautionary tale in the global effort to fight the disease.
Why journal publishing should be upended from the current model, in which institutions pay publishers for access to content, to one in which the academic community pays for services to publish content and retains ownership of research.
Researchers hope that a more pluralistic parliament will put an end to interference and slipping standards.
Biochemist Lynn Kamerlin tells Nature why she has coordinated an open letter - signed by more than 950 scientists - objecting to Plan S.
Many scientists still not bothering to address an issue that undermines the reproducibility of research findings.
Editors of academic journals have started noticing a trend: Women - who inevitably shoulder a greater share of family responsibilities - seem to be submitting fewer papers, while men are submitting up to 50 percent more than they usually would.
There are good reasons for why academicians should care about citations to scholarly articles. An important one is that members of the academy operate essentially as independent contractors.
Although citations and related metrics like the H-index are widely used in academia to evaluate research and allocate resources, the referencing decisions on which they are based are poorly understood. This paper investigates whether authors reference works that influenced them most or those they believe the readers will value most.
The rise of fake news has dominated the world of politics recently, but fake news is not at all new in the world of science.
Some U.S. researchers knew of a Chinese scientist's intentions to implant edited embryos but were unable to stop him. Now scientific institutions are trying to devise global safeguards.
Wiley claim they are committed to moving towards greater openness and reproducibility of research, including increasing transparency in peer review
Effort aims to identify what's ethical and legal-and what's not.
An algorithm makes highly precise predictions about who will win the Nobel Prize but disagrees with the committee on the 2008 prize winner.
The privacy backlash over Cambridge Analytica and Facebook may lead to explosive consequences for academics.
Even women researchers are more likely to choose men to review their academic papers.
Environmental scientists and policymakers value long-term research to an extent that far outstrips the amount of funding awarded for it.
For those interested in knowing what is in the world around them, the current news is disgusting. All US Environmental Protection Agency grants have been frozen, and employees are being prohibited from discussing the changes or talking to the public.
Nick Fowler and Gerard Meijer on the future of Open Access in Germany. Will the negotiations continue?
Big data bibliometrics must take into account qualitative analyses of research as a social institution, rooted in history, economics and politics.
Taking time out to have a child should not mean derailing a research career, says Adrienne Hopkins, lead author of LERU's new paper on family leave.
Wolfram Schultz, Peter Dayan, and Ray Dolan have today been awarded the €1 million Brain Prize by Denmark’s Lundbeck Foundation.
We have developed an analysis pipeline to facilitate real-time mutation tracking in SARS-CoV-2, focusing initially on the Spike (S) protein because it mediates infection of human cells and is the target of most vaccine strategies and antibody-based therapeutics.
Science posted the most comprehensive [3]guidelines for the publication of studies in basic science to date, calling for the adoption of clearly defined rules on the sharing of data and methods.
